Product Information
ARFORMOTEROL 15 MCG/2 ML SOLN is a generic product labeled by Ritedose Pharmaceuticals, LLC, priced at $0.6202 per ML under NDC 76204002602. Its NADAC has been published 170 times since Jul 5, 2023.
FDA first approved this application on Mar 2, 2022. Its Orange Book therapeutic-equivalence code is AN.
Strength
15 ug/2mL
Manufacturer
Ritedose Pharmaceuticals, LLCNDC
76204002602
Classification
Generic
Dosage Form
SOLUTION
Route
RESPIRATORY (INHALATION)
Effective Date
9/23/2026
Active Ingredients
ARFORMOTEROL TARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA214736FDA Approved
3/2/2022
TE Code
AN
On Market Since
2/27/2023
Pharmacological Classes
Price Statistics
The NADAC for ARFORMOTEROL 15 MCG/2 ML SOLN has been published 170 times since Jul 5, 2023, and over the history we have for it it has declined 64.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6202 per ML |
|---|---|
| All-time high | $1.7884 (Jan 10, 2024) |
| All-time low | $0.6202 (Sep 23, 2026) |
| 52-week high | $0.7666 |
| 52-week low | $0.6202 |
| Median price | $0.7992 |
| Average price | $0.9849 |
| Largest weekly change | +40.5% (Nov 22, 2023) |
| Weeks tracked | 170 |
| Tracking since | Jul 5, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Arformoterol Tartrate Inhalation Solution market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Ritedose Pharmaceuticals, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Arformoterol Tartrate Inhalation Solution market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta2-Adrenergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ARFORMOTEROL 15 MCG/2 ML SOLN?
The current National Average Drug Acquisition Cost (NADAC) for ARFORMOTEROL 15 MCG/2 ML SOLN, manufactured by Ritedose Pharmaceuticals, LLC, is $0.6202 per ML (NDC 76204002602), effective Sep 30, 2026.
How has the price of ARFORMOTEROL 15 MCG/2 ML SOLN changed over time?
Over the history we have for it, the NADAC for ARFORMOTEROL 15 MCG/2 ML SOLN has declined 64.7%. It has been tracked across 170 weekly CMS publications since Jul 5, 2023.
What are the highest and lowest recorded NADAC prices for ARFORMOTEROL 15 MCG/2 ML SOLN?
Since Jul 5, 2023, the NADAC for ARFORMOTEROL 15 MCG/2 ML SOLN has ranged from a low of $0.6202 (Sep 23, 2026) to a high of $1.7884 (Jan 10, 2024), with a median of $0.7992 per ML.
Are there cheaper alternatives to ARFORMOTEROL 15 MCG/2 ML SOLN?
No other NADAC-published product currently shares the active ingredient and strength of ARFORMOTEROL 15 MCG/2 ML SOLN in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ARFORMOTEROL 15 MCG/2 ML SOLN?
ARFORMOTEROL 15 MCG/2 ML SOLN (NDC 76204002602) is labeled by Ritedose Pharmaceuticals, LLC, and CMS classifies it as a generic product.